Girard Partners’s Dentsply Sirona XRAY Stock Holding History

Girard Partners’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$37K	–	839
2018 Q3	$37K	Buy	+1,000	New	+$41.6K	0.01%	502

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Girard Partners's XRAY Position: Q4 2018 in Review

Girard Partners sold out of Dentsply Sirona (XRAY) in Q4 2018, closing a stake of 1,000 shares — an estimated $37K sold.

Girard Partners first reported a position in XRAY in Q3 2018 and held it in 1 quarter. The position peaked at $37K in Q3 2018. 494 funds tracked by Wall St. Rank hold XRAY as of Q4 2018.

Girard Partners reported no remaining Dentsply Sirona position as of Q4 2018 after selling out during the quarter.
Girard Partners sold 1,000 Dentsply Sirona shares in Q4 2018, an estimated $37K.
Girard Partners first reported a position in Dentsply Sirona in Q3 2018 and held it in 1 quarter.
Girard Partners's Dentsply Sirona position peaked at $37K in Q3 2018.
494 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.